THE SIMMONS & RUSSELL GROUP, LLC for ELI LILLY AND COMPANY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare Part D coverage and reimbursement policies. Issues related to Medicaid reimbursement. Issues related to drug pricing; Prescription Drug Pricing Reduction Act of 2019, S.2543.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Budget/Appropriations BUD
Monitoring healthcare issues related to the Further Consolidated Appropriations Act, 2020, H.R.1865, P.L.116-94.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Taxation/Internal Revenue Code TAX
Issues related to the implementation of the Tax Cuts and Jobs Act, P.L.115-97.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Pharmacy PHA
Issues related to the pharmaceutical industry including drug pricing, drug value, and the 340B Program. Issues related to healthcare policy and cost; Lower Health Care Costs Act of 2019, S.1895.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.